SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...
About 43% of patients with sarcoidosis received treatment within 1 year of diagnosis, according to study findings published in Chest. Researchers evaluated treatment rates, treatm ...
Some drugs can affect the results and need to be stopped before the test. Patients taking hydrocortisone or prednisone for adrenal insufficiency need to hold the medicine for 24 hours before the test ...